Kinesia™ products are used as outcome measures in Phase I, II, III, and IV clinical trials.

Kinesia technology is integrated in clinical trials around the globe for Parkinson’s disease, essential tremor, and other movement disorders. The intelligent remote sensing technology improves efficiency with web applications, expands accessibility, and has been shown to increase sensitivity and reliability of outcome measures (1,2).

Clinical Trial Services

  • Protocol Support Integration

  • Site Training

  • Custom Training Materials

  • Custom Site Guides

  • Equipment Shipping Logistics

  • Data Management

  • Kinesia Web Portal Management

  • Cellular Data Management

  • Study Technical Support

How to Select Objective Wearables for Parkinson's Trials


  1. Heldman D.A., Espay A.J., LeWitt P.A., and Giuffrida J.P. Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson’s disease. Parkinsonism and Related Disorders,  2014; Jun;20(6):590-5.
  2. Heldman D.A., Urrea Mendoza E, Lovera LC, Schmerler DA, Garcia JXO, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH. App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson’s Disease: Reliability and Responsiveness. J Parkinsons Dis. 2017; 7(4):741-747.